Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001083002 | SCV000261107 | benign | Multiple endocrine neoplasia, type 2 | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411512 | SCV000489791 | likely benign | Multiple endocrine neoplasia type 2B | 2016-03-02 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409060 | SCV000489792 | likely benign | Multiple endocrine neoplasia type 2A | 2016-03-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575112 | SCV000674774 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000205202 | SCV001144499 | benign | not provided | 2018-09-27 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000575112 | SCV002529966 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-10 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000205202 | SCV004220041 | benign | not provided | 2018-09-27 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001083002 | SCV004815192 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-18 | criteria provided, single submitter | clinical testing |